Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.
- DOI
- 10.1016/j.jacc.2026.05.025
- Published
- 2026 Aug 25
- Container
- Journal of the American College of Cardiology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jacc.2026.05.025,
title = {Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.},
author = {Kaul U and Sinha SK and Singh R and Parida AK and Mody R and Abhaichand R and Banker D and Khan A and Kalyansundaram A and Moorthy N and Sharma R and Chandra S and Bordoloi N and Kumar D and Chandra Koduganti S and Gunasekaran S and Kapoor R and Baruah R and Mantri RR and Patil R and Sharma Y and Agrawal DK and Ragava PV and Garg R and Reddy KMK and Chandra P and Kumar S and Arambam P and Khan N and Sudhir K and Bangalore S and TUXEDO- 2 India Investigators},
year = {2026},
journal = {Journal of the American College of Cardiology},
doi = {10.1016/j.jacc.2026.05.025},
url = {https://doi.org/10.1016/j.jacc.2026.05.025}
}RIS
TY - JOUR TI - Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial. AU - Kaul U AU - Sinha SK AU - Singh R AU - Parida AK AU - Mody R AU - Abhaichand R AU - Banker D AU - Khan A AU - Kalyansundaram A AU - Moorthy N AU - Sharma R AU - Chandra S AU - Bordoloi N AU - Kumar D AU - Chandra Koduganti S AU - Gunasekaran S AU - Kapoor R AU - Baruah R AU - Mantri RR AU - Patil R AU - Sharma Y AU - Agrawal DK AU - Ragava PV AU - Garg R AU - Reddy KMK AU - Chandra P AU - Kumar S AU - Arambam P AU - Khan N AU - Sudhir K AU - Bangalore S AU - TUXEDO- 2 India Investigators PY - 2026 JO - Journal of the American College of Cardiology DO - 10.1016/j.jacc.2026.05.025 UR - https://doi.org/10.1016/j.jacc.2026.05.025 ER -
APA
U, K., SK, S., R, S., AK, P., R, M., R, A., D, B., A, K., A, K., N, M., R, S., S, C., N, B., D, K., S, C. K., S, G., R, K., R, B., RR, M., R, P., Y, S., DK, A., PV, R., R, G., KMK, R., P, C., S, K., P, A., N, K., K, S., S, B., & Investigators, T. 2. I. (2026). Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2026.05.025
Source records
- pubmed · retrieved 2026-09-27T00:34:24.710Z
- europe-pmc · retrieved 2026-09-27T00:34:24.718Z